Table 1.
Total | Non-pSS | pSS | |
---|---|---|---|
Patients (n) | 50 | 25 | 25 |
Female (n[%]) | 46[92] | 21[84] | 25[100] |
Age (yr) | 51.34±14.83 | 50.00±12.84 | 52.89±17.07 |
FS+ (n[%]) | 22[44] | 1[4] | 21[84] |
ANA+ (n[%]) | 37[74] | 12[48] | 25[100] |
SSA+ (n[%]) | 19[38] | 0[0] | 19[76] |
SSB+ (n[%]) | 8[16] | 0[0] | 8[32] |
RF+ (n[%]) | 19[38] | 3[12] | 16[64] |
Acinar atrophy | 26[52] | 9[36] | 17[68] |
Abbreviations: FS+, focus score >1; ANA+, antinuclear antibody positive; SSA, anti-SSA antibodies; SSB, anti-SSB antibodies; RF, rheumatoid factor.